Merck & Co., Inc. (MRK) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Merck & Co., Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
14.42
Strong
WeakModerateStrong
P/B Ratio
5.01
Moderate
WeakModerateStrong
Earnings Yield
6.93%
Strong
WeakModerateStrong
Profitability Health
2025Return on Equity
34.70%
Strong
WeakModerateStrong
Operating Margin
36.17%
Strong
WeakModerateStrong
Net Profit Margin
28.12%
Strong
WeakModerateStrong
Growth Indicators
2025Revenue Growth
1.18%
Weak
WeakModerateStrong
Net Income Growth
6.64%
Weak
WeakModerateStrong
EPS Growth
7.99%
Weak
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
1.54
Moderate
WeakModerateStrong
Quick Ratio
1.30
Moderate
WeakModerateStrong
Asset Turnover
0.47x
Weak
WeakModerateStrong
Inventory Turnover
2.73x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
4.69%
Strong
WeakModerateStrong
EV / Free Cash Flow
24.22x
Strong
WeakModerateStrong
Net Debt / EBITDA
1.27x
Moderate
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.897
Moderate
WeakModerateStrong
Return on Invested Capital
18.27%
Moderate
WeakModerateStrong
Cash Conversion Cycle
116.49 days
Weak
WeakModerateStrong
Fortress screener guardrails
2/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for MRK.
View Financial Statements